1 suspended. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Suspended 1 |
| Phase 2 | 1 | Suspended 1 |
Follow BeEAM Regimen: new trials by email Literature Review of BeEAM Regimen trials Research Report on BeEAM Regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas Brentuximab Vedotin, BeEAM Regimen - Lymphoma | Phase 1 / Phase 2 | Suspended | Insel Gruppe AG, University Hospital Bern | 20 | 2018-09-01 | 2025-03-30 |
Lymphoma (1)
Insel Gruppe AG, University Hospital Bern (1)
Switzerland (1)
Thomas Pabst, MD (1)